Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yan-Rong Li

Showing results (51-60 of 81) with videos related to

Pageof 9
Sort By:
Diabetology & Metabolic Syndrome|September 22, 2017
Moderate- to high-intensity statins for secondary prevention in patients with type 2 diabetes mellitus on dialysis after acute myocardial infarctionYan-Rong Li, Sung-Sheng Tsai, Yu-Sheng Lin, et al.
Frontiers in Pharmacology|October 17, 2022
Statin uses in adults with non-dialysis advanced chronic kidney disease: Focus on clinical outcomes of infectious and cardiovascular diseasesChing-Chung Hsiao, Jih-Kai Yeh, Yan-Rong Li, et al.
Acta Diabetologica|January 15, 2025
Glucagon-like peptide 1 receptor agonists outperform basal insulin in cardiovascular and renal outcomes for type 2 diabetes mellitus: a retrospective cohort studyTien-Hsing Chen, Chin-Ju Tseng, Yan-Rong Li, et al.
Frontiers in Endocrinology|September 16, 2024
Synergistically improved cardiovascular outcomes in type 2 diabetes mellitus patients with combined treatment of SGLT-2 inhibitors and pioglitazoneYan-Rong Li, Chih-Ching Wang, Chi-Hung Liu, et al.
Biomedical Journal|November 22, 2021
Evaluation of recurrence risk in patients with papillary thyroid cancer through tumor-node-metastasis staging: A single-center observational study in TaiwanJui-Hung Sun, Yan-Rong Li, Kuo-Hsuan Chang, et al.
Scientific Reports|March 24, 2021
Similar major cardiovascular outcomes between pure statin and ezetimibe-statin in comparable intensity for type 2 diabetes with extremely atherosclerotic risksYu-Cheng Kao, Tien-Hsing Chen, Chi-Hung Liu, et al.
Zhongguo Ji Sheng Chong Xue Yu Ji Sheng Chong Bing Za Zhi = Chinese Journal of Parasitology & Parasitic Diseases|August 22, 2018
[Data Integration and Information Sharing of Parasite Resources in Fujian Province]Li-sha Li, Rong-yan Zhang, Bao-jian Chen, et al.
Journal of Personalized Medicine|September 28, 2021
The Risk of Bladder Cancer in Type 2 Diabetes Mellitus with Combination Therapy of SGLT-2 Inhibitors and PioglitazoneYan-Rong Li, Chi-Hung Liu, Wei-Chiao Sun, et al.
Zhongguo Ji Sheng Chong Xue Yu Ji Sheng Chong Bing Za Zhi = Chinese Journal of Parasitology & Parasitic Diseases|August 24, 2012
[Surveillance on the prevalence of soil-transmitted nematode infection in Fujian in 2006-2010]Bao-jian Chen, Li-sha Li, Rong-yan Zhang, et al.
Plos Medicine|July 19, 2021
Telmisartan use and risk of dementia in type 2 diabetes patients with hypertension: A population-based cohort studyChi-Hung Liu, Pi-Shan Sung, Yan-Rong Li, et al.
Pageof 9

Showing results (51-60 of 81) with videos related to

Sort By:
Pageof 9
Diabetology & Metabolic Syndrome|September 22, 2017
Moderate- to high-intensity statins for secondary prevention in patients with type 2 diabetes mellitus on dialysis after acute myocardial infarctionYan-Rong Li, Sung-Sheng Tsai, Yu-Sheng Lin, et al.
Frontiers in Pharmacology|October 17, 2022
Statin uses in adults with non-dialysis advanced chronic kidney disease: Focus on clinical outcomes of infectious and cardiovascular diseasesChing-Chung Hsiao, Jih-Kai Yeh, Yan-Rong Li, et al.
Acta Diabetologica|January 15, 2025
Glucagon-like peptide 1 receptor agonists outperform basal insulin in cardiovascular and renal outcomes for type 2 diabetes mellitus: a retrospective cohort studyTien-Hsing Chen, Chin-Ju Tseng, Yan-Rong Li, et al.
Frontiers in Endocrinology|September 16, 2024
Synergistically improved cardiovascular outcomes in type 2 diabetes mellitus patients with combined treatment of SGLT-2 inhibitors and pioglitazoneYan-Rong Li, Chih-Ching Wang, Chi-Hung Liu, et al.
Biomedical Journal|November 22, 2021
Evaluation of recurrence risk in patients with papillary thyroid cancer through tumor-node-metastasis staging: A single-center observational study in TaiwanJui-Hung Sun, Yan-Rong Li, Kuo-Hsuan Chang, et al.
Scientific Reports|March 24, 2021
Similar major cardiovascular outcomes between pure statin and ezetimibe-statin in comparable intensity for type 2 diabetes with extremely atherosclerotic risksYu-Cheng Kao, Tien-Hsing Chen, Chi-Hung Liu, et al.
Zhongguo Ji Sheng Chong Xue Yu Ji Sheng Chong Bing Za Zhi = Chinese Journal of Parasitology & Parasitic Diseases|August 22, 2018
[Data Integration and Information Sharing of Parasite Resources in Fujian Province]Li-sha Li, Rong-yan Zhang, Bao-jian Chen, et al.
Journal of Personalized Medicine|September 28, 2021
The Risk of Bladder Cancer in Type 2 Diabetes Mellitus with Combination Therapy of SGLT-2 Inhibitors and PioglitazoneYan-Rong Li, Chi-Hung Liu, Wei-Chiao Sun, et al.
Zhongguo Ji Sheng Chong Xue Yu Ji Sheng Chong Bing Za Zhi = Chinese Journal of Parasitology & Parasitic Diseases|August 24, 2012
[Surveillance on the prevalence of soil-transmitted nematode infection in Fujian in 2006-2010]Bao-jian Chen, Li-sha Li, Rong-yan Zhang, et al.
Plos Medicine|July 19, 2021
Telmisartan use and risk of dementia in type 2 diabetes patients with hypertension: A population-based cohort studyChi-Hung Liu, Pi-Shan Sung, Yan-Rong Li, et al.
Pageof 9